News Releases

Sen. Moran Commemorates 40th Anniversary of National Cancer Act

Announces bipartisan resolution sponsored by more than 40 Senators, endorsed by University of Kansas Cancer Center

WASHINGTON, D.C. – U.S. Senator Jerry Moran (R-KS) today commemorated the 40th anniversary of the signing of the National Cancer Act and announced the introduction of a bipartisan resolution recognizing our nation’s commitment to cancer research. Sen. Moran is the lead Republican sponsor of the resolution, which has more than 40 Senate co-sponsors and is supported by more than 100 patient groups, cancer institutes, hospitals and medical schools including the University of Kansas Cancer Center. More than 12 million Americans have survived cancer thanks in part to the United States’ commitment to cancer research and due to advances in cancer prevention, detection, diagnosis and treatment.

“With passage of the National Cancer Act 40 years ago this month, our nation coordinated a focused effort to combat cancer through research,” Sen. Moran said. “Today, the National Cancer Institute and its parent agency, the National Institutes of Health, support critical research across the country, enhancing the work of universities, medical schools, teaching hospitals, private bioscience businesses and research institutions in every state. This national commitment to research has saved millions of lives and billions of dollars."

“Since the National Cancer Act was signed into law in 1971, the 5-year survival rate for all cancers combined has risen consistently,” Sen. Moran continued. “As a direct result of our nation’s commitment to cancer research, we have come to understand more about the nature of cancer, its complexity, and the tools needed to fight this disease effectively. But much work remains – more than 1.5 million Americans are expected to be diagnosed with cancer this year. With this resolution, we reaffirm our commitment to advancing important cancer research and saving lives."

Given the vast amount of progress made over the last century and the great potential current research holds, Sen. Moran believes the United States must not waiver on its commitment to advancing disease cures and treatments. In September, he offered an amendment in the Senate Appropriations Committee markup to restore funding to the National Institutes of Health (NIH) budget. This amendment was fully offset and would have prioritized medical research without adding a dime to our nation’s annual deficit.